Orthofix Medical
OFIX
158 hedge funds and large institutions have $980M invested in Orthofix Medical in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 15 closing their positions.
36% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 50
2.29% more ownership
Funds ownership: 94.83% → 97.12% (+2.3%)
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
2% more capital invested
Capital invested by funds: $956M → $980M (+$23.7M)
1% more funds holding
Funds holding: 157 → 158 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$22M |
| 2 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$21.3M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$5.98M |
| 4 |
Millennium Management
New York
|
+$5.2M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$11.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.3M |
| 3 |
Morgan Stanley
New York
|
-$8.84M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$8.57M |
| 5 |
Renaissance Technologies
New York
|
-$7.93M |
OFIX Hedge Fund Activity: Q3 2019 in Review
158 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q3 2019, worth a combined $980M — up 2.5% from $956M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new OFIX positions and 15 closed out — a net gain of 1 holder — while 68 added to existing stakes and 50 trimmed.
The largest buyer was Norges Bank, opening a new position worth an estimated $22M. The largest seller was Ameriprise, cutting an estimated $11.9M.
- 158 institutional investors held Orthofix Medical (OFIX) as of Q3 2019, up from 157 in Q2 2019.
- Funds reported $980M of Orthofix Medical stock for Q3 2019, up 2.5% quarter-over-quarter.
- 16 funds opened new Orthofix Medical positions in Q3 2019 and 15 closed out, a net change of +1 holder.
- The largest Orthofix Medical buyer in Q3 2019 was Norges Bank, an estimated $22M added.
- The largest Orthofix Medical seller in Q3 2019 was Ameriprise, an estimated $11.9M sold.
Based on aggregated 13F filings for Q3 2019.